rs2290089

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001378414.1(HDAC4):​c.491-176T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.617 in 151,940 control chromosomes in the GnomAD database, including 29,608 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.62 ( 29608 hom., cov: 31)

Consequence

HDAC4
NM_001378414.1 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.00600

Publications

6 publications found
Variant links:
Genes affected
HDAC4 (HGNC:14063): (histone deacetylase 4) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It possesses histone deacetylase activity and represses transcription when tethered to a promoter. This protein does not bind DNA directly, but through transcription factors MEF2C and MEF2D. It seems to interact in a multiprotein complex with RbAp48 and HDAC3. [provided by RefSeq, Jul 2008]
HDAC4 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with central hypotonia and dysmorphic facies
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • 2q37 microdeletion syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001378414.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-239164099-A-C is Benign according to our data. Variant chr2-239164099-A-C is described in ClinVar as Benign. ClinVar VariationId is 1246960.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.726 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378414.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HDAC4
NM_001378414.1
MANE Select
c.491-176T>G
intron
N/ANP_001365343.1A0A7I2SVS4
HDAC4
NM_001378415.1
c.491-176T>G
intron
N/ANP_001365344.1A0A7I2SVS4
HDAC4
NM_001378416.1
c.491-176T>G
intron
N/ANP_001365345.1P56524-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HDAC4
ENST00000543185.6
TSL:5 MANE Select
c.491-176T>G
intron
N/AENSP00000440481.3A0A7I2SVS4
HDAC4
ENST00000345617.7
TSL:1
c.491-176T>G
intron
N/AENSP00000264606.3P56524-1
HDAC4
ENST00000463007.5
TSL:1
n.943-176T>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.617
AC:
93644
AN:
151820
Hom.:
29596
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.541
Gnomad AMI
AF:
0.703
Gnomad AMR
AF:
0.470
Gnomad ASJ
AF:
0.653
Gnomad EAS
AF:
0.460
Gnomad SAS
AF:
0.745
Gnomad FIN
AF:
0.740
Gnomad MID
AF:
0.620
Gnomad NFE
AF:
0.677
Gnomad OTH
AF:
0.593
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.617
AC:
93686
AN:
151940
Hom.:
29608
Cov.:
31
AF XY:
0.618
AC XY:
45863
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.541
AC:
22410
AN:
41426
American (AMR)
AF:
0.469
AC:
7152
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.653
AC:
2263
AN:
3468
East Asian (EAS)
AF:
0.460
AC:
2365
AN:
5144
South Asian (SAS)
AF:
0.746
AC:
3602
AN:
4828
European-Finnish (FIN)
AF:
0.740
AC:
7797
AN:
10542
Middle Eastern (MID)
AF:
0.633
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
0.677
AC:
46012
AN:
67956
Other (OTH)
AF:
0.596
AC:
1258
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1785
3569
5354
7138
8923
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.654
Hom.:
51024
Bravo
AF:
0.589
Asia WGS
AF:
0.614
AC:
2137
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.3
DANN
Benign
0.56
PhyloP100
-0.0060
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2290089;
hg19: chr2-240085795;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.